Natco Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO PHARMA LTD, and what generic and branded alternatives to NATCO PHARMA LTD drugs are available?
NATCO PHARMA LTD has seventeen approved drugs.
There are two tentative approvals on NATCO PHARMA LTD drugs.
Summary for Natco Pharma Ltd
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 17 |
| Drug Master File Entries: | 43 |
Drugs and US Patents for Natco Pharma Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma Ltd | ARMODAFINIL | armodafinil | TABLET;ORAL | 202768-001 | Nov 28, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma Ltd | ANASTROZOLE | anastrozole | TABLET;ORAL | 079220-001 | Jun 28, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma Ltd | LANTHANUM CARBONATE | lanthanum carbonate | TABLET, CHEWABLE;ORAL | 090978-002 | Aug 11, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma Ltd | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203478-002 | Jul 1, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
